<?xml version="1.0"?>
<rss version="2.0">
  <channel>
    <title>RxPG News : Crohn's Disease</title>
      <link>http://www.rxpgnews.com/</link>
      <description>Medical News and Information</description>
      <pubDate>Thu, 21 Aug 2008 02:00:28 PST</pubDate>
      <language>en-us</language>
      <item>
        <title>Crohn&#39;s disease or gastrointestinal endometriosis?</title>
        <link>http://www.rxpgnews.com/crohnsdisease/Crohn_s_disease_or_gastrointestinal_endometriosis_90825.shtml</link>
        <category>Crohn&#39;s Disease</category>
        <description>Crohn&#39;s disease may mimic gastrointestinal endometriosis in its clinical presentation.A case report published on January 7, 2008 in the World Journal of Gastroenterology describes such a patient.&lt;br/&gt;
&lt;br/&gt;
</description>
        <pubDate>Fri, 22 Feb 2008 08:03:09 PST</pubDate>
        <guid isPermaLink="true">http://www.rxpgnews.com/crohnsdisease/Crohn_s_disease_or_gastrointestinal_endometriosis_90825.shtml</guid>
      </item>
      <item>
        <title>Alternative strategy better for Crohn&#39;s Disease</title>
        <link>http://www.rxpgnews.com/crohnsdisease/Alternative_strategy_better_for_Crohn_s_Disease_90816.shtml</link>
        <category>Crohn&#39;s Disease</category>
        <description>An international research study, published in The Lancet, has thrown into question the current method of treating Crohn’s disease – opening the door to a safer and more effective treatment option for sufferers of the chronic disease.</description>
        <pubDate>Fri, 22 Feb 2008 06:52:59 PST</pubDate>
        <guid isPermaLink="true">http://www.rxpgnews.com/crohnsdisease/Alternative_strategy_better_for_Crohn_s_Disease_90816.shtml</guid>
      </item>
      <item>
        <title>Adalimumab is an effective treatment for refractory Crohn&#39;s disease</title>
        <link>http://www.rxpgnews.com/crohnsdisease/Adalimumab_is_an_effective_treatment_for_refractory_Crohn_s_disease_26095.shtml</link>
        <category>Crohn&#39;s Disease</category>
        <description>A study led by Mayo Clinic found that adalimumab (HUMIRA&amp;reg;)) is an effective treatment for adults with Crohn&#39;s disease who do not respond to infliximab (REMICADE&amp;reg;) therapy. These findings were published online today by Annals of Internal Medicine.</description>
        <pubDate>Tue, 01 May 2007 11:26:54 PST</pubDate>
        <guid isPermaLink="true">http://www.rxpgnews.com/crohnsdisease/Adalimumab_is_an_effective_treatment_for_refractory_Crohn_s_disease_26095.shtml</guid>
      </item>


  </channel>
</rss>
